Showing results (2911-2920 of 13,858) with videos related to
Sort By:
Pageof 1,386
American Heart Journal|October 21, 2018
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductPhilip Joseph, Prem Pais, Antonio L Dans, et al.American Heart Journal|October 21, 2018
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) studyAruna D Pradhan, Nina P Paynter, Brendan M Everett, et al.American Heart Journal|August 1, 1988
Effects of acute intrathoracic pressure changes on left ventricular geometry and fillingS Iliceto, M Dambrosio, M Sorino, et al.American Heart Journal|May 1, 1985
Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery diseaseL Roy, J Mehta, P MehtaAmerican Heart Journal|May 1, 1985
Inhibition of demand pacemakers by myopotentialsJ Gialafos, A Maillis, C Kalogeropoulos, et al.American Heart Journal|August 1, 1988
Comparable effects of intravenous nitroglycerin and intravenous nitroprusside in acute ischemiaW M Breisblatt, D L Navratil, M J Burns, et al.American Heart Journal|July 29, 2019
The prevalence of atrial fibrillation on 48-hour ambulatory electrocardiography in African Americans compared to Whites: The Atherosclerosis Risk in Communities (ARIC) studyLaura R Loehr, Elsayed Z Soliman, Anna K Poon, et al.American Heart Journal|January 1, 1991
The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro studyR Hernandez Hernandez, A R Carvajal, J Guerrero Pajuelo, et al.American Heart Journal|March 29, 2008
Antiplatelet drug nonresponsivenessPatrick Gladding, Mark Webster, John Ormiston, et al.American Heart Journal|March 29, 2008
Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patientsXacobe Flores-Ríos, Raquel Marzoa-Rivas, Juan Pablo Abugattás-de Torres, et al.Pageof 1,386